Evaluating breast cancer risk: Available models to assess individual breast cancer risk and probability to be a BRCA mutation carrier

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 3 SUPPL., 2002, Pages 23-29

  Pasini, B ^a   Cavalchini, G C Casalis ^a   Genovese, T ^b   Manoukian, S ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

BRCA1 and BRCA2; Breast cancer; Penetrance; Risk factors; Risk models

Indexed keywords

ADULT; AGE; ANAMNESIS; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CASE REPORT; CONFERENCE PAPER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GERM LINE; HIGH RISK POPULATION; HUMAN; ONCOGENE; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MODELS, STATISTICAL; MUTATION; PEDIGREE; PENETRANCE; PROBABILITY; RISK; RISK FACTORS;

EID: 0036767391     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Peto J.: Breast cancer susceptibility-A new look at an old model. Cancer Cell 1: 411-412, 2002.
2. Rebbeck T.R.: The contribution of inherited genotype to breast cancer. Breast Cancer Res. 4: 85-89, 2002.
3. Claus E.B., Risch N., Thompson W.D.: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73: 643-651, 1994.
4. Gail M.H., Brinton L.A., Byar D.P., Corle D.K., Green S.B., Schairer C., Mulvihill J.J.: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl. Cancer Inst. 81:1879-1886, 1989.
5. Benichou J., Gail M.H., Mulvihill J.J.: Graphs to estimate an individualized risk of breast cancer. J. Clin. Oncol. 14: 103-110, 1996.
6. Stoutjesdijk M., Boetes C., Jager G.J., et al.: Magnetic resonance imaging and mammography in women with hereditary risk of breast cancer. J. Natl. Cancer Inst. 93: 1095-1102, 2001.
7. Tilanus-Linthorst M.M..M., Obdeijn I.M., Bartels K.C.M., de Koning H.J., Oudkerk M.: First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res. Treat. 63: 53-60, 2000.
8. Fisher B., Costantino J.P., Wickerham D.L., et al.: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 90: 1371-1388, 1998.
9. Lynch H.T., Watson P., Conway T., Fitzsimmons M.L., Lynch J.: Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res. Treat. 11: 263-267, 1988.
10. Hall J.M., Lee M.K., Newman B., Morrow J.E., Anderson L.A., Huey Y.B., King M.C.: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990.
11. Wooster R., Neuhausen S.L., Mangion J., et al.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2090, 1994.
12. Malkin D., Li F.P., Strong L.C., et al.: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238, 1990.
13. Miki Y., Swensen J., Shattuck-Eidens D., et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994.
14. Wooster R., Bignell G, Lancaster J., et al.: Identification of the breast Cancer susceptibility gene BRCA2. Nature 378: 789-792, 1995.
15. http://www.myriad.com/med/index.html (Myriad Genetics, genetic testing).
16. Couch F.J., DeShano M.L., Blackwood M.A. et al.: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 1997 May 15;336(20):1409-15.Shattuck-Eidens D., Oliphant A., McClure M. et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA. 278: 1242-1250, 1997.
17. Couch F.J., DeShano M.L., Blackwood M.A. et al.: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 1997 May 15;336(20):1409-15.Shattuck-Eidens D., Oliphant A., McClure M. et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA. 278: 1242-1250, 1997.
18. Berry D.A., Parmigiani G., Sanchez J., Schildkraut J. and Winer E.: Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J. Natl. Cancer Inst. 89: 227-238, 1997.
19. Frank T.S., Manley S.A., Olapade O.I. et al.: Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J. Clin. Oncol. 16: 2417-2425, 1998.
20. http://www.myriad.com/gtmp.htlm (Myriad Genetics Prevalence Tables).
21. Hartge P., Struewing J.P., Wacholder S., Brody L.C. and Tucker M.A.: The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am. J. Hum. Genet. 64: 963-970, 1999.
22. Parmigiani G., Berry D.A., Aguilar O.: Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am. J. Hum. Genet. 62: 145-158, 1998.
23. http://www3.utsouthwestern.edu/cancergene/ (University of Texas, Southwestern Medical Center, Dallas).